Publications by authors named "Tomohiro Takata"
Article Synopsis
- - Pulmonary arterial hypertension (PAH) is a serious condition that typically requires treatments like pulmonary vasodilators, but new drug developments are exploring different mechanisms, particularly targeting specific patient needs.
- - A connection has been found between interleukin-6 (IL-6) levels and PAH, leading researchers to investigate this cytokine as a potential target for treatment in patients showing elevated IL-6.
- - A clinical study is currently being conducted to see if an antibody called satralizumab can effectively treat PAH in patients identified through biomarker profiles, focusing on those with increased IL-6 levels.
Atrial fibrillation is a clinically important arrhythmia. There are some reports on machine learning models for AF diagnosis using electrocardiogram data. However, few reports have proposed an eXplainable Artificial Intelligence (XAI) model to enable physicians to easily understand the machine learning model's diagnosis results.
View Article and Find Full Text PDF